Questions about COVID-19?

What Patients & Families Need to Know | New Visitor PolicyGuidance for Community Healthcare Providers

A photo of Paul Kingma.

Neonatal Director, Cincinnati Fetal Center

Director, Bronchopulmonary Dysplasia (BPD) Center

Associate Professor, UC Department of Pediatrics



Board Certified

My Biography & Research


Paul S. Kingma, MD, PhD, serves as an attending physician in the Cincinnati Children’s NICU and as neonatal director of the Cincinnati Fetal Center. Dr Kingma leads several basic science and translation research projects that focus on four primary goals.

The first goal is to improve our understanding of pathogenesis of congenital diaphragmatic hernia (CDH). To this end, Dr. Kingma’s laboratory is developing novel methods for measuring lung injury in CHD infants and he has advanced the use of airway pressure release ventilation as a method of reducing lung injury in infants with CDH. In addition, as part of a collaboration with Dr. Jason Woods, Dr. Kingma is using novel MRI-based methods to measure lung growth and function in CDH infants.

The second goal is to improve our understanding of the formation, repair and prognosis of tracheal esophageal (TE) defects. Dr. Kingma is using novel MRI techniques for evaluating tracheal and esophageal morphology in infants with TE defects. In addition, Dr. Kingma is leading an effort to gather detailed anatomic, genetic and clinical outcome data on a large cohort of patients with TE defects in order enhance diagnosis, predict patients at risk for complications, and ultimately improve treatment.

The third goal is to develop effective clinical management strategies to prevent and treat intestinal dysfunction and feeding intolerance in infants with gastroschisis. Dr. Kingma is currently leading a Gerber Foundation funded study that is using MRI to quantify intestinal factors that lead to enteral feeding intolerance.

The final goal of is to improve our understanding of the molecular pathogenesis of neonatal lung injury. Specifically, Dr. Kingma is evaluating the role of the Surfactant Protein D (SP-D) and the pulmonary innate immune system. In addition, Dr. Kingma is part of a Cincinnati Children's Hospital Medical Center collaboration that is developing SP-D as a therapeutic agent designed to improve surfactant function and reduce lung injury in premature infants.

Clinical Interests

Neonatology; fetal care; neonatal care of infants with congenital malformations including congenital diaphragmatic hernia, tracheal-esophageal defects and gastroschisi

Research Interests

Innate immune systems; surfactant protein D; Neonatal lung growth; genetic basis of congenital malformations

Academic Affiliation

Associate Professor, UC Department of Pediatrics


Congenital Diaphragmatic Hernia, Newborn Intensive Care NICU, Neonatology, Perinatal, Fetal Care, Bronchopulmonary Dysplasia BPD, Neonatology, Pulmonary Biology

My Locations

My Education

BS: Calvin College, MI, 1992.

MD: Vanderbilt University, TN, 2000.

PhD: Vanderbilt University, TN, 2000.

Residency: Cincinnati Children's Hospital Medical Center, 2003.

Fellowship: Cincinnati Children's Hospital Medical Center, 2005.

My Publications

Neonatal lung growth in congenital diaphragmatic hernia: evaluation of lung density and mass by pulmonary MRI. Adaikalam, SA; Higano, NS; Tkach, JA; Yen Lim, F; Haberman, B; Woods, JC; Kingma, PS. Pediatric Research. 2019; 86:635-640.

Evaluation of Lung Injury in Infants with Congenital Diaphragmatic Hernia. Marks, KT; Landis, MW; Lim, FY; Haberman, B; Kingma, PS. Journal of Pediatric Surgery. 2019; 54:2443-2447.

Congenital diaphragmatic hernia: the good, the bad, and the tough. Aydin, E; Lim, F; Kingma, P; Haberman, B; Rymeski, B; Burns, P; Peiro, JL. Pediatric Surgery International. 2019; 35:303-313.

Quantitative Assessment of Regional Dynamic Airway Collapse in Neonates via Retrospectively Respiratory-Gated H-1 Ultrashort Echo Time MRI. Bates, AJ; Higano, NS; Hysinger, EB; Fleck, RJ; Hahn, AD; Fain, SB; Kingma, PS; Woods, JC. Journal of Magnetic Resonance Imaging. 2019; 49:659-667.

The Surfactant System. Kingma, P; Jobe, AH. Kendig's Disorders of the Respiratory Tract in Children. 2019.

Evaluation of Early Onset Sepsis, Complete Blood Count, and Antibiotic Use in Gastroschisis. Williams, SL; Leonard, M; Hall, ES; Perez, J; Wessel, J; Kingma, PS. American Journal of Perinatology: neonatal and maternal-fetal medicine. 2018; 35:385-389.

Pre- and post-operative visualization of neonatal esophageal atresia/tracheoesophageal fistula via magnetic resonance imaging. Higano, NS; Bates, AJ; Tkach, JA; Fleck, RJ; Lim, FY; Woods, JC; Kingma, PS. Journal of Pediatric Surgery Case Reports. 2018; 29:5-8.

Diagnosing Infection in a Neonate Using Whole-Body Screening Magnetic Resonance Imaging. Fu, TT; Kingma, PS. Pediatrics. 2017; 140:e20160732-e20160732.

Quantification of Neonatal Lung Parenchymal Density via Ultrashort Echo Time MRI With Comparison to CT. Higano, NS; Fleck, RJ; Spielberg, DR; Walkup, LL; Hahn, AD; Thomen, RP; Merhar, SL; Kingma, PS; Tkach, JA; Fain, SB; et al. Journal of Magnetic Resonance Imaging. 2017; 46:992-1000.

Evaluation of Neonatal Lung Volume Growth by Pulmonary Magnetic Resonance Imaging in Patients with Congenital Diaphragmatic Hernia. Schopper, MA; Walkup, LL; Tkach, JA; Higano, NS; Lim, FY; Haberman, B; Woods, JC; Kingma, PS. The Journal of Pediatrics. 2017; 188:96-102.e1.